WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) hit a new 52-week high during trading on Wednesday. The company traded as high as $27.80 and last traded at $27.80, with a volume of 220 shares changing hands. The stock had previously closed at $26.48.
Analyst Ratings Changes
Separately, Zacks Research upgraded WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Strong Buy”.
Get Our Latest Stock Report on WuXi AppTec
WuXi AppTec Stock Up 3.1%
WuXi AppTec Company Profile
WuXi AppTec is a contract research, development and manufacturing organization (CRDMO) that provides services to pharmaceutical, biotechnology and medical-device companies. Its offerings span the drug-development process, including early-stage discovery, medicinal and synthetic chemistry, biology research, analytical testing, preclinical studies, clinical research support, process development and commercial manufacturing.
The company supports a broad range of therapeutic programs, with capabilities covering small-molecule drugs, biologics, chemical and pharmaceutical products, and cell and gene therapies.
Featured Stories
- Five stocks we like better than WuXi AppTec
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
- 3 Emerging Biotech Stocks With Significant Upside Potential
- Treasury Yields Haven’t Been This High Since 2007—3 ETFs to Watch
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
